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This work was performed to elucidate further the main cellular events underlying the protective effect of ischaemic precon-
ditioning in an in vivo rat liver model of 90 min ischaemia followed by 30 min reperfusion. A significant attenuation of the
various aspects of post-ischaemic injury, namely necrosis and the levels of hydrogen peroxide and 5- and 15-hydroperox-
yeicosatetraenoic acids, was afforded by the prior application of a short cycle of ischaemia/reperfusion (10þ 10 min) or
when rats were previously treated with gadolinium chloride. However, when preconditioning was applied on Kupffer
cell-depleted livers, no additional level of ischaemic tolerance was obtained. In terms of cellular pathology, this result could
be suggestive of Kupffer cells as the target of the preconditioning phenomenon during the warm ischaemia/reperfusion
injury. Accordingly, modulation of Kupffer cell activity was associated with a well-preserved hepatocyte integrity, together
with low levels of pro-oxidant generation during reperfusion. As activated Kupffer cells can generate and release potentially
toxic substances, their modulation by ischaemic preconditioning could help to provide new surgical and/or pharmacological
strategies to protect the liver against reperfusion damage. Copyright # 2003 John Wiley & Sons, Ltd.
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INTRODUCTION
Substantial evidence indicates that Kupffer cells play
a central role in the pathogenesis of liver parenchymal
cell damage during the early post-reperfusion phase,
mainly through releasing ROS and other toxic media-
tors (i.e. cytokines) able to modulate hepatocyte meta-
bolism and function.1,3–5 In light of this and in order to
improve liver function after reperfusion, various
attemps have been made to block Kupffer cell activity,
either through administration of specific toxins (e.g.
GdCl3, dichloromethylene diphosphonate), methyl-
xanthine phosphodiesterase inhibitors (i.e. pentoxifyl-
line) or by the use of calcium blocking agents (e.g.
nisoldipine). However, the side-effects of these treat-
ments cannot be entirely excluded.1,3–9
The term IP was coined to describe a protective
mechanism against ischaemia–reperfusion injury and
consists of previous short periods of ischaemia fol-
lowed by reperfusion.10 It was originally described
in the heart, where it decreases infarct size after sub-
sequent prolonged ischaemia and reperfusion.11
In the liver, the exact mechanisms involved in the
status of cytoprotection conferred by IP against ischae-
mia/reperfusion injury are not fully understood. How-
ever experimental data suggest that modifications of the
endothelin-1/nitric oxide ratio in favour of the latter,
changes in energy metabolism, attenuation of in situ
TNF- production and release, as well as a blocking
effect on the ROS-generating systems, are actively
implicated.12–17 Moreover, since the liver is composed
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of a heterogeneous cell population, it is likely that dur-
ing preconditioning complex cross-talk could take
place between parenchymal and non-parenchymal cells.
Accordingly, we investigated the effects of IP on
Kupffer cell activity in a rat liver model of ischae-
mia/reperfusion injury.
MATERIALS AND METHODS
Animal model
Male Sprague-Dawley rats (224 5 g body weight)
were used; they had free access to standard chow diet
and water. After anesthesia with 10% ketamine chlor-
hydrate solution, they were positioned under a heat
lamp to maintain constant body temperature. After a
midline laparotomy, selective inflow occlusion of the
portal triad (hepatic artery, portal vein, and bile duct)
to the left and median liver lobes was performed.
Reperfusion was initiated by clamp removal. Samples
from the post-ischaemic lobes were taken at the end of
the reperfusion phase, and biochemical and morpho-
logical studies were carried out. All animals received
humane care according to the criteria outlined in
Guide for the Care and Use of Laboratory Animals.18
Depletion of Kupffer cells
To inhibit Kupffer cell activity, a randomized set of
rats were treated with gadolinium chloride (GdCl3;
10 mg kg1 in sterile 0.9% NaCl solution, i.v.) 18 h
before the ischaemia and reperfusion cycle.3
Experimental design
The rats were subdivided into six groups, each group
being of five animals.
Group 1. Sham saline: animals treated with sterile
0.9% NaCl solution were subjected to anesthaesia and
laparotomy alone.
Group 2. Sham GdCl3: as in group 1, but rats were
treated with GdCl3 instead of sterile 0.9% NaCl
solution.
Group 3. Standard Ischaemia/Reperfusion (Isch/Rep):
rats were subjected to 90 min of ischaemia followed by
30 min of reperfusion.
Group 4. IPþ Isch/Rep: before ischaemia/reperfusion,
rats were subjected to 10 min ischaemia followed by
10 min reperfusion.17
Group 5. GdCl3þ Isch/Rep: before ischaemia/reper-
fusion, rats were treated with GdCl3.
Group 6. GdCl3þ IPþ Isch/Rep: before IP procedure,
as in group 4, rats were treated with GdCl3.
Biochemical assessment of liver cytolysis
Irreversible hepatic damage was evaluated by deter-
mination of alanine aminotransferase and aspartate
aminotransferase in blood-plasma obtained from the
posterior cava vein after 30 min of reperfusion, using
a commercial kit from Sigma Chemical Co. (St. Louis
MO, USA).
H2O2 analysis
Specimens from sham-operated and reperfused livers
were homogenized (10%, w/v) in a buffer containing
0.033 mol l1 Na2HPO4 and 0.9% KCl, pH 7.4 at 4C.
The homogenates were centrifuged at 40,000 g for
45 min and the supernatant was used for H2O2 analy-
sis. The H2O2-mediated oxidation of Fe
2þ to Fe3þ ion,
under acidic conditions and in the presence of xylenol
orange dye, was quantified as described elsewhere.19
For the working reagent, 1 ml solution A containing
ammonium ferrous sulphate (25 mM) and sulphuric
acid (2.5 mM) was mixed with 100 ml of solution B
containing sorbitol (100 mM) and xylenol orange
(125 mmol l1 in water. A 0.1-ml volume of superna-
tant was added to 1 ml of working reagent, mixed
and incubated at room temperature for 15 min. The
absorbance was read at 560 nm. The values were
read against a standard curve prepared with 1 to
50 mmol l1 concentrations of H2O2. The absolute
values of H2O2 were expressed in mmol l
1.
Determination of 5- and 15-HPETE
The concentration of 5- and 15-HPETE in the lipid
fraction from cytosol samples extracted by the method
of Folch et al.20 was determined by the method of
Tordijman et al.,21 slightly modified. Briefly, determi-
nation was by high performance liquid chromatogra-
phy analyses with a Symmetry C18 columm. The
mobile phase used was a mixture of 0.05 M NaH2PO4,
pH 5/methanol/acetonitrile (30:35:35, v:v). The
HPETE levels in the samples were calculated by com-
parison with standard solutions of 5- and 15-HPETE
(Sigma, St Louis, MO, USA). The results were ex-
pressed as mM.
Number of neutrophils
Fragments from the left lateral lobe of about 1.0
0.5 0.3 cm were placed overnight in a solution of
4% formaldehyde in 50 mM phosphate buffer solution,
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pH 7.4. Polymorphonuclear leukocytes (PMN) were
identified on 5-mm paraffin sections by means of the
naphthol AS-D chloroacetate technique for esterase,
following the method described by Moloney et al.22
with slight modifications; the substrate was dissolved
in dimethyl sulphoxide/Triton X-100 (9:1, v/v) and
then 0.1% Fast Garnet dGBC in 0.1 M phosphate buf-
fer solution, pH 8.5 was added. Red stained PMN
were counted in 20 non-consecutive, randomly
chosen 500 histological fields. Results were ex-
pressed as the number of neutrophils per
40 histological power field (hpf ).
Protein determination
The protein content of the liver homogenates was
determined by the spectrophotometric method des-
cribed by Peterson23 using bovine serum albumin as
standard.
Statistical analysis
Data are presented as means SE; the statistical sig-
nificance of differences was analysed using the one-
way analysis of variance (ANOVA) corrected by the
Tukey–Kramer Multiple Comparisons test and with
the Student t test where p values 0.05 were consid-
ered to be statistically significant.
RESULTS
In our experimental model, long-term ischaemia
followed by reperfusion induced hepatic necrosis in
both non-preconditioned and preconditioned animals.
However, a marked reduction of irreversible cell
injury was detectable when IP had previously been
applied (Figure 1).
Among non-parenchymal liver cells, Kupffer cells
are thought to constitute the major source of toxic
mediators, namely ROS, released immediately after
Figure 1. Ischaemic preconditioning and gadolinium chloride treatment attenuate the post-ischaemic irreversible damage of the liver. Data
are presented as means SE. p< 0.05; a versus sham; b versus Isch/Rep; $ versus Isch/Rep from 0.9% NaCl-treated rats
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reperfusion.1,3,6 Cytolysis was also significantly at-
tenuated in animals previously treated with GdCl3
(Figure 1). However, the degree of ischaemic tolerance
was not improved if preconditioning was previously
applied to Kupffer cell-depleted rats (Figure 1).
In this study, we examined the changes in concentra-
tions of H2O2 and 5- and 15-HPETE during the course
of the ischaemia/reperfusion injury, as by-products of
the activity of the Kupffer cell’s NADPH oxidase and
5-lipoxygenase.4,25,26 To exclude neutrophils as pos-
sible sources of 5-lipoxygenase-derived hydroxyperox-
ides,27 we evaluated the number of naphthol-AS-D-
chloroacetate-positive infiltrating leukocytes.
After ischaemia and reperfusion, a 2.6-fold increase
in the concentrations of H2O2 was seen in the group of
rats treated with 0.9% NaCl. This level of oxidative
stress was reduced by 31% however, when the animals
were previously submitted to GdCl3 treatment
(Table 1). Similarly, IP was able to protect against
post-reperfusion generation of H2O2 in the 0.9%
NaCl-treated group (47% decrease). However, when
the IP procedure was applied to the Kupffer cell-
depleted livers, no additional attenuation over the
level of H2O2 production was observed (Table 1).
Similarly, GdCl3 treatment and IP were able to
attenuate the increased production of 5-lipoxygen-
ase-derived lipid hydroperoxides following ischae-
mia/reperfusion (Figure 2). However, in the liver
Table 1. Hepatic concentration of hydrogen peroxide after
reperfusion (mmoles)
Groups
0.9% NaCl treated GdCl3 treated
Sham 1.20 0.08 1.40 0.06
Isch/Rep 3.20 0.09* 2.20 0.17*,z
PrecþIsch/Rep 1.70 0.17*,y 2.00 0.17y
Data are presented as meansSE.
p< 0.05; *versus sham; yversus Isch/Rep; zversus Isch/Rep from
0.9% NaCl-treated rats.
Figure 2. Ischaemic preconditioning and gadolinium chloride treatment attenuate the post-ischaemic generation of 5- and 15-
hydroperoxyeicosatetraenoic acids. Data are presented as means SE. p< 0.05; a versus sham; b versus Isch/Rep;$ versus Isch/Rep from
0.9% NaCl-treated rats
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depleted of Kupffer cells, IP did not accentuate the
inhibitory effect over 5- and 15-HPETE production,
so differences brought about by preconditioning of
the liver cannot be discerned. Moreover, the fact that
there was no change in the number of neutrophils seen
in the reperfused livers allowed these cells to be ruled
out as possible sources of 5- and 15-HPETE (Table 2).
DISCUSSION
A prominent feature of ischaemia and reperfusion
leading to liver damage is the activation of Kupffer
cells.1,3,6 Activated Kupffer cells are involved in
the development of liver cell injury through produc-
tion of ROS and inflammatory mediators, which
directly contribute to the sinusoidal dysfunction and
hepatocyte damage and death during the early phase
of reperfusion, and indirectly by promoting neutro-
phil recruitment and initiation of inflammatory
responses.28,29 Modulation of Kupffer cell activity
attenuated the early post-reperfusion damage. Accor-
dingly, depletion of Kupffer cells with GdCl3 was
associated with a well-preserved hepatocyte integrity,
together with low levels of pro-oxidant generation
during reperfusion.
Products of lipid peroxidation, other than 4
hydroxy-2, 3-trans-nonenal and malondialdehyde,
namely 5-lipoxygenase-derived lipid hydroperoxides,
are also known to be toxic to cells.30 As the enzyme 5-
lipoxygenase is present only in the non-parenchymal
cells of the liver, namely Kupffer cells,31 measure-
ment of its biological by-products at the end of the
early phase of reperfusion studied here, could provide
a functional index of Kupffer cell activity.
Are Kupffer cells targets of IP? A hallmark of this
study is that application of IP to the livers allows us to
reproduce practically identical findings to those
obtained through GdCl3 treatment, i.e. cytolysis and
tissue oxidative stress were attenuated. However,
when Kupffer cell-depleted livers were precondi-
tioned, no additional level of tolerance against post-
ischaemic damage was obtained. Moreover, the levels
of H2O2 and 5- and 15-HPETE were almost identical
to those obtained by either GdCl3 treatment or IP
alone. In our opinion, this fact constitutes evidence
that a main mechanism of action of preconditioning
against in vivo reperfusion injury could be the modu-
lation of Kupffer cells activity. Accordingly, recent
experiments from an isolated perfused rat liver model
have shown that IP protects sinusoidal endothelial
cells and suppresses Kupffer cell activation after cold
storage and reperfusion.32,33
Could there be any mechanism(s) of cell damage
not susceptible to modulation by IP? This question
emerges because of the residual cytolysis and tissue
oxidative stress found at the end of the reperfusion
phase in both preconditioned and GdCl3-treated
livers. A probable explanation for these results could
be that neither IP nor GdCl3 treatment are sufficient to
attenuate the irreversible cell damage and the pro-oxi-
dant levels generated during the sustained ischaemic
phase.
The present study does not address the mechanisms
by which IP offers tolerance against sustained ischae-
mia/reperfusion injury, but in terms of cellular pathol-
ogy, it indicates Kupffer cells as a target of IP during
this in vivo model of warm ischaemia/reperfusion
injury to the liver. We would like to think that some
mediator(s) formed during the brief cycle of ischae-
mia/reperfusion (10 minþ 10 min) are able to modu-
late Kupffer cell activity. In agreement with this,
adenosine has been implicated as an important media-
tor of cardiac and liver IP,13,34 and it has been reported
that adenosine is able to prevent activation of Kupffer
cells and to suppress TNF- release from them.15
During ischaemia, ATP is rapidly degraded to ade-
nosine. Adenosine modulates several tissue functions
through receptor-mediated mechanisms. Adenosine
receptors differ in their biological and pharmacologi-
cal responses to adenosine agonists and antagonists.35
Adenosine A1 receptors stimulate inhibitory G-pro-
teins that block adenylate cyclase and decrease cAMP.
By contrast, activation of A2 receptors stimulates ade-
nylate cyclase and increases cAMP. Accordingly, in
recent experiments carried out with a cold storage
model of liver injury, it was reported that adenosine
mediates IP to sinusoidal endothelial cells through
A2 receptors and that adenosine A2 receptor agonists,
as well as cAMP, protect preconditioned sinusoidal
endothelial cells against cold storage/reperfusion
injury to the same extent as brief cycles of ischae-
mia–reperfusion (preconditioning phenomenon).36
Because adenosine suppresses endotoxin-stimu-
lated tumour necrosis factor- formation by Kupffer
cells via an adenosine A2 receptor pathway,
37 it seems
Table 2. Number of neutrophils in the liver after reperfusion
(PMN/hpf )
Groups
0.9% NaCl treated GdCl3 treated
Sham 2.0 0.2 2.0 1.0
Isch/Rep 7.5 2.0* 7.5 2.0*
PrecþIsch/Rep 10.0 3.0* 8.5 3.0*
Data are presented as meansSE.
p< 0.05; *versus sham.
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reasonable to believe that adenosine released by pre-
conditioning interferes in some step(s) of the mechan-
ism involved in the activation of the Kupffer cells’
NADPH oxidase and 5-lipoxygenase enzymes, i.e.
blocking the post-reperfusion release of toxic media-
tors: H2O2 and 5- and 15-HPETE. Accordingly, it has
been documented that intracellular cAMP-elevating
agents have been shown to be associated with the
downregulation of the oxidative burst and the inhibi-
tion of the 5-lipoxygenase translocation and activation
in both neutrophils and cells of the macrophage/
monocyte lineage.38–41
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